The forecast for the import of blood-grouping reagents to Japan from 2024 to 2028 shows a steady increase from 105.34 thousand kg in 2024 to 119.96 thousand kg in 2028. Compared to prior data, this upward trend suggests growing demand in the Japanese market, likely driven by advancements in medical technology and an aging population requiring more healthcare services. The year-on-year changes indicate a consistent growth pattern, which when compounded over the five-year forecast period, results in a solid average annual growth rate.
Future trends worth monitoring include technological innovations in healthcare diagnostics, regulatory changes affecting imports, and the evolving demographics of Japan's population, potentially further increasing the demand for medical reagents.
